Good news for people newly diagnosed with rare autoimmune disorder: Study finds low relapse risk
People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente study. The work is published in the journal Neurology.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Study finds that genetic risk does not explain the maternal effect in type 1 diabetes
United Kingdom
-
Predicting long-term pain after freezing nerves in surgery
United Kingdom
-
Why eczema increases the risk of asthma in patients
United Kingdom
-
Video-assisted informed consent shortens face-to-face cancer surgery consultations
United Kingdom
-
Targeting brain cleaning gene could help treat or prevent Alzheimer's
United Kingdom
-
New patient-centered initiative aims to accelerate pediatric AML research and treatments
United Kingdom
-
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight
United Kingdom
-
What university campus sewage can reveal about the effects of exam stress
United Kingdom